Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding. Pillar VC led the round with participation from Accanto Partners.
Source: Press Release
Adaptilens fetches $1.6m seed
Boston-based Adaptilens, a developer of an adjustable intraocular lens, has secured $1.6 million in seed funding.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: